| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:407.)
© 2005 American Heart Association, Inc.
Controversies in Stroke |
From The National Stroke Research Institute (G.A.D.), Austin and Repatriation Medical Centre and University of Melbourne; Department of Neurology (S.M.D.), Royal Melbourne Hospital and University of Melbourne, Australia.
Correspondence to Prof Stephen M. Davis, Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia 3050. E-mail stephen.davis@mh.org.au
Section Editors: Geoffrey A. Donnan MD, FRACP Stephen M. Davis MD, FRACP
Key Words: aneurysm subarachnoid hemorrhage surgery
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
It is well known that cerebral aneurysms are surprisingly prevalent in normal individuals and is estimated to be between 3.6% to 6.0% of the population.1 The essential paradox appears to be the dichotomy between the epidemiological data and surgical experience. Wiebers study2 suggests that patients with unruptured cerebral aneurysms <7 mm in diameter have a benign natural history, but this contrasts with the experience of neurosurgeons, such as Weir, who are confronted by a substantial proportion of their patients with subarachnoid hemorrhage because of small ruptured aneurysms.3
How could this paradox be explained? It seems to us that we still have a very incomplete picture of the prevalence, size, distribution, and natural history of unruptured aneurysms over longer time epochs. Furthermore, it is quite possible that aneurysms may form quickly, as suggested by Weir, and rupture early during their expansion phase, although still quite small in diameter. The duration of this growth period to rupture is uncertain. There does seem to be reasonable evidence that aneurysms of
7 mm, once detected (at an uncertain time after their development) have a fairly low rate of rupture over a 5-year period.2 Both clinicians and their patients, however, are concerned about lifetime risk, and long-term data are still lacking.
In assessing the risks and benefits of intervention in a patient who is found to have an unruptured aneurysm, the treatment decision is also influenced by the current evolution in therapeutic strategies. In ruptured cerebral aneurysms, endovascular coiling was shown to be superior to
This article has been cited by other articles:
![]() |
S. Gallas, J. Drouineau, J. Gabrillargues, A. Pasco, C. Cognard, L. Pierot, and D. Herbreteau Feasibility, Procedural Morbidity and Mortality, and Long-Term Follow-Up of Endovascular Treatment of 321 Unruptured Aneurysms AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 63 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Davis and G. A. Donnan Unruptured Brain Arteriovenous Malformations: Another Asymptomatic Conundrum Stroke, December 1, 2007; 38(12): 3312 - 3312. [Full Text] [PDF] |
||||
![]() |
H. Takao and T. Nojo Treatment of Unruptured Intracranial Aneurysms: Decision and Cost-effectiveness Analysis Radiology, September 1, 2007; 244(3): 755 - 766. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |